Antibodies that interact with osteoprotegerin ligand (OPGL) are described. Methods of treating osteopenic disorders by administering a pharmaceutically effective amount of antibodies to OPGL are described. Methods of detecting the amount of OPGL in a sample using antibodies to OPGL are described.
申请公布号
WO03002713(A3)
申请公布日期
2003.08.14
申请号
WO2002US20181
申请日期
2002.06.25
申请人
ABGENIX, INC.;AMGEN, INC.
发明人
BOYLE, WILLIAM, J.;MARTIN, FRANCIS, H.;CORVALAN, JOSE, R.;DAVIS, GEOFFREY, C.
